Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • September 26, 2014:

    NIH through a new program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs). "NIH and Fogarty have had a longstanding interest in the potential of cellphones, smartphones and mobile apps as powerful health intervention tools," said Fogarty Director Dr. Roger I. Glass. "These new mHealth awards will enhance efforts of researchers and clinicians in low-resource settings, while yielding crucial data on implementation, scale-up, and what works and what doesn't."Full Story

  • September 24, 2014:

    Cedars-Sinai physicians and scientists are testing a novel, human cell based, bioartificial liver support system for patients with acute alcohol-related liver failure, often a fatal diagnosis.
    “A bioartificial liver could potentially sustain patients with acute liver failure until their own livers self-repair,” said Steven D. Colquhoun, MD, the surgical director of liver transplantation at Cedars-Sinai’s Comprehensive Transplant Center.Full Story

  • September 18, 2014:

    Nature Communications reports, the researchers behind "Complementation Activated Light Microscopy" (CALM) used it to study dystrophin – a key structural protein of muscle cells – in Caenorhabditis elegans worms used to model Duchenne muscular dystrophy. The new technology allows imaging resolutions that are an order of magnitude finer than conventional optical microscopy, providing new insights into the behavior of biomolecules at the nanometer scale and led to the discovery that dystrophin was responsible for defective mechanical responses and the calcium imbalance that impair normal muscle activity in patients with muscular dystrophy.Full Story

  • September 16, 2014:

    Responding to the urgent physician need for better designed and user-friendly Electronic Hospital Records (EHR) systems, the AMA today released a new framework outlining eight priorities for improving EHR usability to benefit caregivers and patients.
    The AMA/RAND study findings show physicians are concerned current EHR technology requires too much time-consuming data entry, leaving less time for patients. Numerous other studies support these findings, including a recent survey by International Data Corporation that found 58 percent of ambulatory physicians were not satisfied with their EHR technology, “most office-based providers find workflow, usability, productivity, and vendor quality issues continue to drive dissatisfaction.”Full Story

  • September 4, 2014:

    A six month study found that a non-invasive Revita Duodenal Mucosal Resurfacing (DMR) procedure designed to alter the inner surface of the duodenum and change how the body absorbs and processes sugar was completed in Santiago, Chile. The Revita DMR procedure, announced by Fractyl Laboratories, has the potential to delay the need for insulin therapy and free patients from the burdens associated with managing type 2 diabetes. The study results were presented in late August at the 19th World Congress of International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO 2014) meeting in Montreal, Canada. Full Story

  • September 3, 2014:

    A Scientific team including University of Oregon chemist Geraldine Richmond and study co-author Ronald Zuckermann of the Molecular Foundry at Lawrence Berkeley National Laboratory (LBNL) who first developed these ultra-thin nanosheets in 2010 have tapped oil and water to create scaffolds of self-assembling, synthetic proteins called peptoid nanosheets that could become improved chemical sensors and separators, and safer, more effective drug-delivery vehicles.. Full Story

  • September 2, 2014:

    Polina Anikeeva, the MIT Assistant Professor in Materials Science and Engineering, develops both flexible electronic devices and safe chemical methods to manipulate nerve cells in the brain and spinal cord. These flexible polymer probes and magnetic nanoparticles promise breakthroughs for treating paralysis and brain disease. "We are hoping to use our devices to record a pattern of neural activity coming from the brain and translate it across the injury site into a pattern of stimulation. We can do it optically, and that's why we try to incorporate electronic and optical features within these flexible polymer probes," Anikeeva explains. Full Story